arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Hinge Health, Inc.

HNGE

$89.36 ▲ +9.36 (+11.70%) at close

11 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Hinge Health, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $7.0B

Dividend Yield —

Revenue Growth 47.2% ↗

Op. Margin 17.6% ↗

ROIC 28.1% ↗

FCF / Share $0.55

Trailing P/E 207.8x

Price / Book 62.9x

FCF Yield 0.6%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$182.31M

↑ +47.2% —

Net Income Profit after all expenses

$35.13M

↑ +105.0% —

Operating Margin Operating profit as % of sales

17.6%

↑ +10.2% 2th

FCF / Share Free cash flow per share

$0.55

↑ +72.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	47.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+294%)	45.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+280%)	53.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+344%)	54.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+357%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	-94.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	5.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	N/M	-1264.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	105.0% Excellent Excellent Year-over-year change in net income	18.4% Good Good Year-over-year change in net income	N/M	N/M	—	—	—	—	—	—	—
FCF Growth YoY (%)	72.0% Excellent Excellent Year-over-year change in free cash flow	—	-49.3% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Operating Margin (%) (%)	17.6% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-12%)	16.0% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-20%)	-4.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-120%)	-417.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2187%)	10.6% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-47%)	17.8% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-11%)	-3.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-119%)	-19.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-198%)	—	—	—
Effective Tax Rate (%) (%)	2.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-12.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	5.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-3.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	76.5% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
Profit Margin (%) (%)	19.3% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+28%)	18.8% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+25%)	11.1% Fair ↓ Fair Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-26%)	12.3% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-18%)	13.8% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-8%)	23.1% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+54%)	-26.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-275%)	-29.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-296%)	—	—	—
FCF Margin (%) (%)	23.6% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	37.2% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	53.4% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	14.4% Fair ↓ Fair Declining Free cash flow as a percentage of revenue Optimal: > 10%	3.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	32.6% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	27.9% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	1.22x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	1.98x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	4.80x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.41x Good Good Free cash flow relative to reported net income Optimal: > 1x	-1.06x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	28.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	15.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-334.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	0.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	3.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	4.4% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	3.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-0.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-83.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	3.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	31.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+70%)	18.0% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	8.2% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-55%)	9.9% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-47%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	-6.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	5.7% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-69%)	5.7% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-69%)	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Net Debt (USD)	$-186.67M	$-208.00M	$-261.34M	$-237.17M	$-288.48M	$-300.79M	$-267.53M	$-236.63M	—	$-234.95M	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	$2.32	—	$1.96	$3.17	$8.08	—	$7.39	$6.64	—	—	—
Basic EPS, GAAP (USD)	$0.43	$2.11	$-0.02	$-13.10	$7.91	$2.01	$0.01	$-0.96	—	—	—
Free Cash Flow per Share (USD)	$0.55	—	$1.04	$0.46	$0.32	—	$2.06	—	—	—	—
Book Value per Share (USD)	$1.42	—	$2.64	$3.96	$-20.11	$-26.53	$-33.90	$-34.20	—	—	—
Tangible Book Value per Share (USD)	$0.58	—	$1.79	$2.43	$-20.11	$-30.40	$-33.90	$-34.20	—	—	—
Basic Weighted Avg Shares (shares)	78.62M	—	78.86M	43.93M	15.33M	—	13.62M	13.53M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$125.58M	$171.50M	$301.81M	$284.34M	—	$334.15M	—	—	—	—	—
Total Equity (USD)	$111.69M	$178.66M	$208.00M	$173.78M	$-308.28M	$-434.57M	$-461.77M	$-462.61M	$-450.20M	$-423.99M	$-318.12M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$182.31M	$170.73M	$154.21M	$139.10M	$123.83M	$117.26M	$100.61M	$89.83M	—	—	—
Depreciation Expense (USD)	$300.00K	$300.00K	$300.00K	$300.00K	$300.00K	$500.00K	$500.00K	$500.00K	—	—	—
Net Income, GAAP (USD)	$35.13M	$32.09M	$17.14M	$17.14M	$17.14M	$27.12M	$-26.46M	$-26.46M	—	—	—
Operating Cash Flow (USD)	$43.08M	$63.89M	$82.40M	$20.23M	$4.92M	$38.34M	$28.40M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 11 quarters

Hinge Health, Inc.

Analytical Summary

11-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HNGE with peers